van Gilst WH - Search Results

1

Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both?

Anthonio RL, van Veldhuisen DJ, van Gilst WH. Anthonio RL, et al. Among authors: van gilst wh, van veldhuisen dj. J Cardiovasc Pharmacol. 1998;32 Suppl 1:S1-8. doi: 10.1097/00005344-199800003-00002. J Cardiovasc Pharmacol. 1998. PMID: 9731689 Review.

2

Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion.

van Wijngaarden J, Tobé TJ, Weersink EG, Bel KJ, de Graeff PA, de Langen CD, van Gilst WH, Wesseling H. van Wijngaarden J, et al. Among authors: van gilst wh. J Cardiovasc Pharmacol. 1992 Mar;19(3):408-16. doi: 10.1097/00005344-199203000-00017. J Cardiovasc Pharmacol. 1992. PMID: 1378122

3

The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs.

Tobé TJ, de Langen CD, Weersink EG, van Wijngaarden J, Bel KJ, de Graeff PA, van Gilst WH, Wesseling H. Tobé TJ, et al. Among authors: van wijngaarden j, van gilst wh. J Cardiovasc Pharmacol. 1992 May;19(5):732-40. J Cardiovasc Pharmacol. 1992. PMID: 1381771 Clinical Trial.

4

Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.

van Wijngaarden J, Monnink SH, Bartels H, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. van Wijngaarden J, et al. Among authors: van gilst wh. J Cardiovasc Pharmacol. 1992 May;19(5):741-7. J Cardiovasc Pharmacol. 1992. PMID: 1381772

5

Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.

van Gilst WH, Tio RA, van Wijngaarden J, de Graeff PA, Wesseling H. van Gilst WH, et al. Among authors: van wijngaarden j. J Cardiovasc Pharmacol. 1992;19 Suppl 5:S134-9. J Cardiovasc Pharmacol. 1992. PMID: 1381790 Review.

6

Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.

Wiesfeld AC, Crijns HJ, Van Veldhuisen DJ, Van Gilst WH, Lie KI. Wiesfeld AC, et al. Among authors: van gilst wh, van veldhuisen dj. Clin Cardiol. 1992 Sep;15(9):689-92. doi: 10.1002/clc.4960150912. Clin Cardiol. 1992. PMID: 1395204 Free article.

7

The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitors.

de Graeff PA, van Gilst WH. de Graeff PA, et al. Among authors: van gilst wh. Agents Actions Suppl. 1992;38 ( Pt 3):110-8. Agents Actions Suppl. 1992. PMID: 1462853 Review.

8

Early ACE-inhibition in myocardial infarction. Possible role of bradykinin.

van Gilst WH, de Graeff PA. van Gilst WH, et al. Agents Actions Suppl. 1992;38 ( Pt 3):80-9. Agents Actions Suppl. 1992. PMID: 1462886 Review.

9

The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.

Van Veldhuisen DJ, Girbes AR, Crijns HJ, Smit AJ, Van Gilst WH, Lie KI. Van Veldhuisen DJ, et al. Among authors: van gilst wh. Int J Clin Pharmacol Res. 1991;11(3):159-65. Int J Clin Pharmacol Res. 1991. PMID: 1687321

10

Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.

van Wijk LM, Crijns HJ, Kingma HJ, van Gilst WH, van Gelder IC, Wesseling H, Lie KI. van Wijk LM, et al. Among authors: van gilst wh, van gelder ic. J Cardiovasc Pharmacol. 1990 Jun;15(6):884-91. J Cardiovasc Pharmacol. 1990. PMID: 1694910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters